Immune tolerance: Parallels between pregnancy and kidney transplantation

Pregnancy represents a unique immunological paradox in which the maternal immune system must tolerate the semi-allogeneic fetus expressing paternal antigens. The success of pregnancy depends on a highly coordinated network of immune tolerance mechanisms, encompassing the placental barrier, chemokine-guided leukocyte migration, restricted alloantigen presentation, regulatory T cells, tolerogenic natural killer cells, immune checkpoint molecules, and both hormonal and metabolic adaptations. In contrast, achieving long-term acceptance of transplanted organs-referred to as "operational tolerance"-remains a formidable clinical challenge that typically necessitates lifelong immunosuppression. Contemporary strategies to induce tolerance focus on the deletion or anergy of donor-reactive immune cells and the utilization of regulatory T cells to suppress rejection. Additional approaches, including co-stimulatory blockade, cell-based therapies, and induction of mixed chimerism via donor stem cell transplantation, seek to replicate these tolerance mechanisms. Ongoing clinical immune monitoring and emerging interventions-such as the inhibition of T-cell signaling, modulation of costimulatory pathways, and targeted expansion of regulatory T cells-are being actively investigated to improve rejection control and foster long-term tolerance. Both pregnancy and organ transplantation challenge the immune system to tolerate foreign antigens. Pregnancy achieves this through specialized placental barriers and regulatory immune adaptations, whereas transplantation relies on immunosuppression because natural tolerance is rare. Key concepts include immune regulation, the role of regulatory T cells, and emerging therapies targeting immune pathways. This review selectively compares these core mechanisms to clarify how lessons from each context can inform strategies for optimizing maternal health and long-term graft success.